Clinical Studies

Developing new treatments is important for continually improving patient care. Please click on the following links to learn more about KalVista's KONFIDENT clinical trial:


KONFIDENT logo

KVD900-301 (KONFIDENT Study) is a Phase 3 clinical trial to evaluate sebetralstat for the on-demand treatment of hereditary angioedema (HAE) attacks. 

Find a Participating Site:

australian-flag

AU

bulgarian-flag

BG

canadian-flag

CA

spain-flag

ES

french-flag

FR

british-flag

GB

greek-flag

GR

hungarian-flag

HU

italian-flag

IT

north-macedonia-flag

MK

netherlands-flag

NL

polish-flag

PL

american-flag

US

(english)

american-flag

US

(español)